CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis
Author
Abate G
Aldar S Bourinbaiar
+41 more
Allen I Bain
Ariungerel Tseveendorj
Arjanova OV
Arjanova OV
Bozóky G
Devadatta S
Dmytro O Butov
Elena A Grinishina
Erkhemtsetseg Chunt
Galitskií LA
Galyna A Kutsyna
Hanna L Stepanenko
Igor V Mospan
John L Rowe
Khaliunaa Baasanjav
Marina G Tarakanovskaya
Mikola E Kovolev
Morris CD
Munkhburam Sandagdorj
Narantsetseg Damdinpurev
Natalia I Makeeva
Nikolaeva LG
Nikolaeva LG
Ochirbat Batbold
Otgonbayar Mijiddorj
Peter Nyasulu
Prihoda ND
Prihoda ND
Prihoda ND
Prihoda ND
Prihoda ND
Pylypchuk VS
Svetlana I Zaitzeva
Tatyana S Butova
Tomasson HO
Uyanga Batbold
Vichai Jirathitikal
Volodymyr S Pylypchuk
Yew WW
Zaitzeva SI
Zaitzeva SI
Publication venue
'Future Medicine Ltd'
Publication date
Field of study
No full text
Crossref